

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 5.08162059 |
| 2 | negative regulation of cell killing (GO:0031342) | 5.08162059 |
| 3 | negative regulation of erythrocyte differentiation (GO:0045647) | 5.00504242 |
| 4 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.81658156 |
| 5 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.80915866 |
| 6 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.60683119 |
| 7 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.57521821 |
| 8 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.43817742 |
| 9 | mannose metabolic process (GO:0006013) | 4.26663232 |
| 10 | detection of bacterium (GO:0016045) | 4.03127782 |
| 11 | detection of other organism (GO:0098543) | 3.92032257 |
| 12 | response to muramyl dipeptide (GO:0032495) | 3.89819940 |
| 13 | regulation of gamma-delta T cell activation (GO:0046643) | 3.82719078 |
| 14 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.74741753 |
| 15 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.74741753 |
| 16 | modulation by symbiont of host immune response (GO:0052553) | 3.74741753 |
| 17 | positive regulation by symbiont of host defense response (GO:0052509) | 3.74741753 |
| 18 | modulation by symbiont of host defense response (GO:0052031) | 3.74741753 |
| 19 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.74741753 |
| 20 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.62608869 |
| 21 | * Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.57899158 |
| 22 | positive thymic T cell selection (GO:0045059) | 3.57840616 |
| 23 | response to peptidoglycan (GO:0032494) | 3.57047607 |
| 24 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.56010857 |
| 25 | thymic T cell selection (GO:0045061) | 3.55948054 |
| 26 | germinal center formation (GO:0002467) | 3.55088466 |
| 27 | NIK/NF-kappaB signaling (GO:0038061) | 3.45652576 |
| 28 | macrophage activation involved in immune response (GO:0002281) | 3.44785494 |
| 29 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.40289800 |
| 30 | regulation of ARF GTPase activity (GO:0032312) | 3.36669531 |
| 31 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.30548948 |
| 32 | negative thymic T cell selection (GO:0045060) | 3.30032696 |
| 33 | neutrophil activation involved in immune response (GO:0002283) | 3.24236234 |
| 34 | detection of external biotic stimulus (GO:0098581) | 3.22767918 |
| 35 | leukocyte aggregation (GO:0070486) | 3.21306383 |
| 36 | T cell selection (GO:0045058) | 3.12877947 |
| 37 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.12236877 |
| 38 | regulation of mast cell degranulation (GO:0043304) | 3.10376380 |
| 39 | immunoglobulin mediated immune response (GO:0016064) | 3.07205890 |
| 40 | B cell receptor signaling pathway (GO:0050853) | 3.05813650 |
| 41 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.05108007 |
| 42 | negative T cell selection (GO:0043383) | 3.04568121 |
| 43 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 3.02705606 |
| 44 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.98608260 |
| 45 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.95298017 |
| 46 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.93596596 |
| 47 | regulation of leukocyte degranulation (GO:0043300) | 2.92559713 |
| 48 | negative regulation of interleukin-12 production (GO:0032695) | 2.92093752 |
| 49 | response to type I interferon (GO:0034340) | 2.90687682 |
| 50 | tolerance induction (GO:0002507) | 2.87792637 |
| 51 | type I interferon signaling pathway (GO:0060337) | 2.85501728 |
| 52 | cellular response to type I interferon (GO:0071357) | 2.85501728 |
| 53 | positive regulation of B cell differentiation (GO:0045579) | 2.85092079 |
| 54 | detection of biotic stimulus (GO:0009595) | 2.84234447 |
| 55 | negative regulation of innate immune response (GO:0045824) | 2.82661420 |
| 56 | regulation of necroptotic process (GO:0060544) | 2.80255896 |
| 57 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.80095725 |
| 58 | response to interleukin-15 (GO:0070672) | 2.77092607 |
| 59 | * actin nucleation (GO:0045010) | 2.76568746 |
| 60 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.73243131 |
| 61 | positive regulation of histone deacetylation (GO:0031065) | 2.70574618 |
| 62 | positive T cell selection (GO:0043368) | 2.70401721 |
| 63 | neutrophil activation (GO:0042119) | 2.69212179 |
| 64 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.67855843 |
| 65 | histone H4 deacetylation (GO:0070933) | 2.66453903 |
| 66 | cellular extravasation (GO:0045123) | 2.64454474 |
| 67 | detection of molecule of bacterial origin (GO:0032490) | 2.62591829 |
| 68 | signal complex assembly (GO:0007172) | 2.62110430 |
| 69 | negative regulation of type 2 immune response (GO:0002829) | 2.61382356 |
| 70 | defense response to protozoan (GO:0042832) | 2.60796134 |
| 71 | regulation of T cell tolerance induction (GO:0002664) | 2.60497017 |
| 72 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 2.59866040 |
| 73 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.59473630 |
| 74 | regulation of natural killer cell mediated immunity (GO:0002715) | 2.58654308 |
| 75 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 2.58654308 |
| 76 | granulocyte activation (GO:0036230) | 2.58427017 |
| 77 | negative regulation of T cell mediated immunity (GO:0002710) | 2.57535080 |
| 78 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.56764321 |
| 79 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.56733860 |
| 80 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.56237917 |
| 81 | cellular response to virus (GO:0098586) | 2.54018009 |
| 82 | regulation of B cell differentiation (GO:0045577) | 2.52698154 |
| 83 | response to host immune response (GO:0052572) | 2.51208910 |
| 84 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.51208910 |
| 85 | negative regulation of toll-like receptor signaling pathway (GO:0034122) | 2.50275057 |
| 86 | myeloid cell activation involved in immune response (GO:0002275) | 2.48465513 |
| 87 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.47571271 |
| 88 | regulation of regulated secretory pathway (GO:1903305) | 2.47344646 |
| 89 | regulation of antigen processing and presentation (GO:0002577) | 2.45278117 |
| 90 | regulation of tolerance induction (GO:0002643) | 2.44566404 |
| 91 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.43684301 |
| 92 | response to protozoan (GO:0001562) | 2.43639450 |
| 93 | histone H3 deacetylation (GO:0070932) | 2.43535716 |
| 94 | positive regulation of Rap GTPase activity (GO:0032854) | 2.43157580 |
| 95 | negative regulation of granulocyte differentiation (GO:0030853) | 2.43039427 |
| 96 | response to host (GO:0075136) | 2.42617247 |
| 97 | response to host defenses (GO:0052200) | 2.42617247 |
| 98 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.42617247 |
| 99 | respiratory burst (GO:0045730) | 2.41928957 |
| 100 | regulation of ARF protein signal transduction (GO:0032012) | 2.39719259 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | VDR_21846776_ChIP-Seq_THP-1_Human | 3.20916517 |
| 2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.90118090 |
| 3 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.87041686 |
| 4 | MYC_22102868_ChIP-Seq_BL_Human | 2.81353448 |
| 5 | LXR_22292898_ChIP-Seq_THP-1_Human | 2.75590835 |
| 6 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.70727945 |
| 7 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 2.48591006 |
| 8 | TCF7_22412390_ChIP-Seq_EML_Mouse | 2.40595626 |
| 9 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 2.39080336 |
| 10 | KDM2B_26808549_Chip-Seq_DND41_Human | 2.37609025 |
| 11 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.27752078 |
| 12 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.22079763 |
| 13 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.17981140 |
| 14 | MAF_26560356_Chip-Seq_TH1_Human | 2.14266568 |
| 15 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.11985016 |
| 16 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.10987102 |
| 17 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.09297562 |
| 18 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 2.07124603 |
| 19 | UTX_26944678_Chip-Seq_JUKART_Human | 1.98125971 |
| 20 | * MAF_26560356_Chip-Seq_TH2_Human | 1.93900637 |
| 21 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.91013778 |
| 22 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.88438665 |
| 23 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.87204202 |
| 24 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.83573308 |
| 25 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.83523254 |
| 26 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.83300094 |
| 27 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.82654745 |
| 28 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.80156776 |
| 29 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.79229768 |
| 30 | P68_20966046_ChIP-Seq_HELA_Human | 1.75854349 |
| 31 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.73790004 |
| 32 | * SPI1_23127762_ChIP-Seq_K562_Human | 1.72510356 |
| 33 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.69189122 |
| 34 | KDM2B_26808549_Chip-Seq_K562_Human | 1.68524315 |
| 35 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.67581252 |
| 36 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.66564023 |
| 37 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.66238163 |
| 38 | * CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.63799243 |
| 39 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.62782157 |
| 40 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.62045976 |
| 41 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.58968875 |
| 42 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.58566591 |
| 43 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.57162279 |
| 44 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.55922734 |
| 45 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.54404247 |
| 46 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.49956065 |
| 47 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.49574186 |
| 48 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.49373904 |
| 49 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.49254424 |
| 50 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.48959608 |
| 51 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.46438319 |
| 52 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.46180779 |
| 53 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.45125134 |
| 54 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.45100988 |
| 55 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.44674535 |
| 56 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.43881544 |
| 57 | GATA1_19941826_ChIP-Seq_K562_Human | 1.42676481 |
| 58 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.41025191 |
| 59 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.36945613 |
| 60 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.36510830 |
| 61 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.36452169 |
| 62 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.35475856 |
| 63 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.33631493 |
| 64 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.33018273 |
| 65 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.32960112 |
| 66 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.32474570 |
| 67 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.32337330 |
| 68 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.32045507 |
| 69 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.31472580 |
| 70 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.27205148 |
| 71 | MYB_26560356_Chip-Seq_TH1_Human | 1.24651355 |
| 72 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.24563579 |
| 73 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.22648019 |
| 74 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.22627532 |
| 75 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.21527566 |
| 76 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.20081136 |
| 77 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.19978535 |
| 78 | MYB_26560356_Chip-Seq_TH2_Human | 1.19941319 |
| 79 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.19870349 |
| 80 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.18415783 |
| 81 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.18377193 |
| 82 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.17788391 |
| 83 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.16253840 |
| 84 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.16098498 |
| 85 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.15023931 |
| 86 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.14674517 |
| 87 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.14277105 |
| 88 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.13787450 |
| 89 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.12680754 |
| 90 | PHF8_20622854_ChIP-Seq_HELA_Human | 1.11617991 |
| 91 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.11616962 |
| 92 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.10744586 |
| 93 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 1.09946243 |
| 94 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.09808894 |
| 95 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.09760491 |
| 96 | SA1_27219007_Chip-Seq_Bcells_Human | 1.09706385 |
| 97 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.09529768 |
| 98 | * RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.09437970 |
| 99 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.07589287 |
| 100 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.06048205 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003436_decreased_susceptibility_to | 4.14700429 |
| 2 | MP0003303_peritoneal_inflammation | 3.46202258 |
| 3 | MP0003724_increased_susceptibility_to | 3.17735121 |
| 4 | MP0005058_abnormal_lysosome_morphology | 3.09949305 |
| 5 | MP0003172_abnormal_lysosome_physiology | 2.93477797 |
| 6 | MP0001835_abnormal_antigen_presentation | 2.71991861 |
| 7 | MP0008260_abnormal_autophagy | 2.55897865 |
| 8 | MP0002419_abnormal_innate_immunity | 2.50156635 |
| 9 | MP0005025_abnormal_response_to | 2.48769087 |
| 10 | MP0000685_abnormal_immune_system | 2.48124160 |
| 11 | MP0001800_abnormal_humoral_immune | 2.43843960 |
| 12 | MP0001790_abnormal_immune_system | 2.42810110 |
| 13 | MP0005387_immune_system_phenotype | 2.42810110 |
| 14 | MP0005000_abnormal_immune_tolerance | 2.42794977 |
| 15 | MP0005671_abnormal_response_to | 2.41340827 |
| 16 | MP0009278_abnormal_bone_marrow | 2.39098525 |
| 17 | MP0005451_abnormal_body_composition | 2.23676259 |
| 18 | MP0003763_abnormal_thymus_physiology | 2.22981748 |
| 19 | MP0004947_skin_inflammation | 2.21012074 |
| 20 | MP0002723_abnormal_immune_serum | 2.19457447 |
| 21 | MP0002420_abnormal_adaptive_immunity | 2.10461465 |
| 22 | MP0001819_abnormal_immune_cell | 2.10329939 |
| 23 | MP0002452_abnormal_antigen_presenting | 2.08772020 |
| 24 | MP0003300_gastrointestinal_ulcer | 2.08213717 |
| 25 | MP0003191_abnormal_cellular_cholesterol | 2.06717095 |
| 26 | MP0009785_altered_susceptibility_to | 1.99371940 |
| 27 | MP0010155_abnormal_intestine_physiology | 1.92644642 |
| 28 | MP0001533_abnormal_skeleton_physiology | 1.86907279 |
| 29 | MP0003705_abnormal_hypodermis_morpholog | 1.86474988 |
| 30 | MP0005464_abnormal_platelet_physiology | 1.83109158 |
| 31 | MP0002405_respiratory_system_inflammati | 1.80461940 |
| 32 | MP0002398_abnormal_bone_marrow | 1.74959985 |
| 33 | MP0009840_abnormal_foam_cell | 1.71122318 |
| 34 | MP0002148_abnormal_hypersensitivity_rea | 1.67629592 |
| 35 | MP0006082_CNS_inflammation | 1.67527027 |
| 36 | MP0009333_abnormal_splenocyte_physiolog | 1.66324991 |
| 37 | MP0000716_abnormal_immune_system | 1.65690026 |
| 38 | MP0005076_abnormal_cell_differentiation | 1.56755523 |
| 39 | MP0001873_stomach_inflammation | 1.53923045 |
| 40 | MP0004510_myositis | 1.52202247 |
| 41 | MP0003866_abnormal_defecation | 1.50568852 |
| 42 | MP0001849_ear_inflammation | 1.49940280 |
| 43 | MP0001545_abnormal_hematopoietic_system | 1.49663203 |
| 44 | MP0005397_hematopoietic_system_phenotyp | 1.49663203 |
| 45 | MP0003183_abnormal_peptide_metabolism | 1.46452148 |
| 46 | MP0002396_abnormal_hematopoietic_system | 1.46450383 |
| 47 | MP0002933_joint_inflammation | 1.46389697 |
| 48 | MP0001845_abnormal_inflammatory_respons | 1.44280440 |
| 49 | MP0004381_abnormal_hair_follicle | 1.41306964 |
| 50 | MP0002722_abnormal_immune_system | 1.39615985 |
| 51 | MP0000858_altered_metastatic_potential | 1.39446417 |
| 52 | MP0000465_gastrointestinal_hemorrhage | 1.39185306 |
| 53 | MP0002429_abnormal_blood_cell | 1.37977419 |
| 54 | MP0002998_abnormal_bone_remodeling | 1.37045835 |
| 55 | MP0003656_abnormal_erythrocyte_physiolo | 1.36946801 |
| 56 | MP0004858_abnormal_nervous_system | 1.35040533 |
| 57 | MP0000689_abnormal_spleen_morphology | 1.34236777 |
| 58 | MP0002132_abnormal_respiratory_system | 1.33989966 |
| 59 | MP0000703_abnormal_thymus_morphology | 1.33482059 |
| 60 | MP0003828_pulmonary_edema | 1.31993761 |
| 61 | MP0008469_abnormal_protein_level | 1.19642562 |
| 62 | MP0005310_abnormal_salivary_gland | 1.08317114 |
| 63 | MP0003329_amyloid_beta_deposits | 1.07856426 |
| 64 | MP0000604_amyloidosis | 1.06202560 |
| 65 | MP0003690_abnormal_glial_cell | 1.05773953 |
| 66 | MP0003453_abnormal_keratinocyte_physiol | 1.05687649 |
| 67 | MP0003279_aneurysm | 1.05290501 |
| 68 | MP0009764_decreased_sensitivity_to | 1.02768527 |
| 69 | MP0000678_abnormal_parathyroid_gland | 0.99107011 |
| 70 | MP0005083_abnormal_biliary_tract | 0.98095234 |
| 71 | MP0001851_eye_inflammation | 0.96792575 |
| 72 | MP0001348_abnormal_lacrimal_gland | 0.96616688 |
| 73 | MP0003091_abnormal_cell_migration | 0.93686640 |
| 74 | MP0005409_darkened_coat_color | 0.93460228 |
| 75 | MP0005390_skeleton_phenotype | 0.91535710 |
| 76 | MP0003075_altered_response_to | 0.89961264 |
| 77 | MP0005360_urolithiasis | 0.87996543 |
| 78 | MP0001663_abnormal_digestive_system | 0.87082748 |
| 79 | MP0002166_altered_tumor_susceptibility | 0.86452432 |
| 80 | MP0001958_emphysema | 0.86038779 |
| 81 | MP0008874_decreased_physiological_sensi | 0.78541559 |
| 82 | MP0003795_abnormal_bone_structure | 0.78288221 |
| 83 | MP0003045_fibrosis | 0.76559324 |
| 84 | MP0005375_adipose_tissue_phenotype | 0.76410963 |
| 85 | MP0005666_abnormal_adipose_tissue | 0.75103840 |
| 86 | MP0004808_abnormal_hematopoietic_stem | 0.74130861 |
| 87 | MP0000249_abnormal_blood_vessel | 0.71804175 |
| 88 | MP0004185_abnormal_adipocyte_glucose | 0.71426844 |
| 89 | MP0002249_abnormal_larynx_morphology | 0.69975818 |
| 90 | MP0005166_decreased_susceptibility_to | 0.69639516 |
| 91 | MP0000003_abnormal_adipose_tissue | 0.69495701 |
| 92 | MP0009931_abnormal_skin_appearance | 0.69045591 |
| 93 | MP0003879_abnormal_hair_cell | 0.68158078 |
| 94 | MP0000609_abnormal_liver_physiology | 0.67785689 |
| 95 | MP0009763_increased_sensitivity_to | 0.63829181 |
| 96 | MP0008004_abnormal_stomach_pH | 0.63518002 |
| 97 | MP0002822_catalepsy | 0.63453242 |
| 98 | MP0004130_abnormal_muscle_cell | 0.61838513 |
| 99 | MP0001853_heart_inflammation | 0.61513246 |
| 100 | MP0001986_abnormal_taste_sensitivity | 0.61422456 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Eczematoid dermatitis (HP:0000976) | 4.92972618 |
| 2 | Recurrent abscess formation (HP:0002722) | 3.67833508 |
| 3 | Myositis (HP:0100614) | 3.66908180 |
| 4 | Recurrent bacterial skin infections (HP:0005406) | 3.62494444 |
| 5 | Abnormality of macrophages (HP:0004311) | 3.60239768 |
| 6 | Increased IgE level (HP:0003212) | 3.25783387 |
| 7 | Orchitis (HP:0100796) | 3.18542092 |
| 8 | Obstructive lung disease (HP:0006536) | 3.14694600 |
| 9 | Chronic obstructive pulmonary disease (HP:0006510) | 3.14694600 |
| 10 | Colitis (HP:0002583) | 3.09570926 |
| 11 | Obstructive sleep apnea (HP:0002870) | 3.06404222 |
| 12 | Mediastinal lymphadenopathy (HP:0100721) | 3.01695807 |
| 13 | Dysostosis multiplex (HP:0000943) | 2.97997050 |
| 14 | Broad face (HP:0000283) | 2.96022025 |
| 15 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.93024208 |
| 16 | Recurrent fungal infections (HP:0002841) | 2.92299881 |
| 17 | Cellulitis (HP:0100658) | 2.92241714 |
| 18 | Gingivitis (HP:0000230) | 2.89758524 |
| 19 | Gastrointestinal infarctions (HP:0005244) | 2.86933389 |
| 20 | Meningitis (HP:0001287) | 2.85560291 |
| 21 | Pustule (HP:0200039) | 2.82249188 |
| 22 | Prolonged bleeding time (HP:0003010) | 2.82024569 |
| 23 | Thin bony cortex (HP:0002753) | 2.81332163 |
| 24 | Optic neuritis (HP:0100653) | 2.75112268 |
| 25 | Retrobulbar optic neuritis (HP:0100654) | 2.75112268 |
| 26 | Gastrointestinal inflammation (HP:0004386) | 2.74878519 |
| 27 | Hemorrhage of the eye (HP:0011885) | 2.73724438 |
| 28 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.64878571 |
| 29 | Inflammation of the large intestine (HP:0002037) | 2.61813204 |
| 30 | Spontaneous hematomas (HP:0007420) | 2.60596722 |
| 31 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.58982614 |
| 32 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.56885984 |
| 33 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.56885984 |
| 34 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.56885984 |
| 35 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.52802038 |
| 36 | Mucopolysacchariduria (HP:0008155) | 2.52802038 |
| 37 | Abnormality of the fingertips (HP:0001211) | 2.52416507 |
| 38 | Metaphyseal cupping (HP:0003021) | 2.50022326 |
| 39 | Malnutrition (HP:0004395) | 2.47742584 |
| 40 | Systemic lupus erythematosus (HP:0002725) | 2.45318864 |
| 41 | J-shaped sella turcica (HP:0002680) | 2.42978864 |
| 42 | Recurrent skin infections (HP:0001581) | 2.39192384 |
| 43 | Loss of speech (HP:0002371) | 2.38155394 |
| 44 | Vasculitis (HP:0002633) | 2.37971424 |
| 45 | Emphysema (HP:0002097) | 2.32779766 |
| 46 | Encephalitis (HP:0002383) | 2.31833180 |
| 47 | Increased cerebral lipofuscin (HP:0011813) | 2.31656847 |
| 48 | Epistaxis (HP:0000421) | 2.30010174 |
| 49 | Stomatitis (HP:0010280) | 2.27373805 |
| 50 | Panhypogammaglobulinemia (HP:0003139) | 2.27233893 |
| 51 | Recurrent viral infections (HP:0004429) | 2.26687013 |
| 52 | Cerebral aneurysm (HP:0004944) | 2.26124448 |
| 53 | Gastrointestinal stroma tumor (HP:0100723) | 2.25164505 |
| 54 | Chest pain (HP:0100749) | 2.24283784 |
| 55 | Recurrent cutaneous fungal infections (HP:0011370) | 2.22652571 |
| 56 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.22652571 |
| 57 | Cervical subluxation (HP:0003308) | 2.19689642 |
| 58 | Purpura (HP:0000979) | 2.17998035 |
| 59 | Pulmonary infiltrates (HP:0002113) | 2.17800941 |
| 60 | Increased serum ferritin (HP:0003281) | 2.15528075 |
| 61 | Hypertensive crisis (HP:0100735) | 2.12543212 |
| 62 | Granulocytopenia (HP:0001913) | 2.10629032 |
| 63 | Reticulocytosis (HP:0001923) | 2.10112928 |
| 64 | Agammaglobulinemia (HP:0004432) | 2.08962102 |
| 65 | Hypochromic anemia (HP:0001931) | 2.08266551 |
| 66 | Easy fatigability (HP:0003388) | 2.07970977 |
| 67 | Keratoconjunctivitis sicca (HP:0001097) | 2.07633282 |
| 68 | Increased connective tissue (HP:0009025) | 2.06613081 |
| 69 | Premature loss of primary teeth (HP:0006323) | 2.04831996 |
| 70 | Hemoptysis (HP:0002105) | 2.04727996 |
| 71 | Distal lower limb amyotrophy (HP:0008944) | 2.03318461 |
| 72 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.01277464 |
| 73 | Petechiae (HP:0000967) | 2.01012081 |
| 74 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.99928795 |
| 75 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.99928795 |
| 76 | Abnormality of glycolipid metabolism (HP:0010969) | 1.99928795 |
| 77 | Urticaria (HP:0001025) | 1.97376642 |
| 78 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.97028321 |
| 79 | Stridor (HP:0010307) | 1.96617286 |
| 80 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 1.95078977 |
| 81 | Restrictive lung disease (HP:0002091) | 1.93919312 |
| 82 | Hypertriglyceridemia (HP:0002155) | 1.92790194 |
| 83 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.92549116 |
| 84 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 1.92537255 |
| 85 | Slow saccadic eye movements (HP:0000514) | 1.90625056 |
| 86 | Increased IgM level (HP:0003496) | 1.90456255 |
| 87 | Osteomyelitis (HP:0002754) | 1.89844567 |
| 88 | Abnormality of the nasal mucosa (HP:0000433) | 1.88010768 |
| 89 | Abnormality of the thoracic spine (HP:0100711) | 1.86749783 |
| 90 | Myopathic facies (HP:0002058) | 1.86600787 |
| 91 | Thoracic kyphosis (HP:0002942) | 1.86055384 |
| 92 | Neuronal loss in central nervous system (HP:0002529) | 1.85618007 |
| 93 | Keratoconjunctivitis (HP:0001096) | 1.83122125 |
| 94 | Polycythemia (HP:0001901) | 1.82423186 |
| 95 | Abnormality of the peritoneum (HP:0002585) | 1.82188505 |
| 96 | Seborrheic dermatitis (HP:0001051) | 1.81190491 |
| 97 | Joint stiffness (HP:0001387) | 1.80496294 |
| 98 | Interstitial pulmonary disease (HP:0006530) | 1.80275518 |
| 99 | Gastrointestinal dysmotility (HP:0002579) | 1.79478560 |
| 100 | Hypergammaglobulinemia (HP:0010702) | 1.79268129 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ERN1 | 3.53481316 |
| 2 | TRIB3 | 3.39054491 |
| 3 | RIPK4 | 3.23149013 |
| 4 | MAP4K1 | 3.13474370 |
| 5 | PRPF4B | 2.62888990 |
| 6 | SIK1 | 2.41122841 |
| 7 | MAP2K3 | 2.30818216 |
| 8 | TNK2 | 2.21031780 |
| 9 | BLK | 1.97277200 |
| 10 | EPHB1 | 1.86023310 |
| 11 | TYK2 | 1.79444330 |
| 12 | ZAP70 | 1.76521358 |
| 13 | MAP3K13 | 1.72717546 |
| 14 | GRK6 | 1.72440018 |
| 15 | MARK2 | 1.70018109 |
| 16 | SIK2 | 1.68995145 |
| 17 | IRAK4 | 1.68319050 |
| 18 | TBK1 | 1.68244386 |
| 19 | MAP3K14 | 1.64121654 |
| 20 | FGFR4 | 1.57784367 |
| 21 | MAP3K11 | 1.56166555 |
| 22 | ICK | 1.53809444 |
| 23 | RIPK1 | 1.48140094 |
| 24 | FES | 1.44507067 |
| 25 | BTK | 1.43125079 |
| 26 | CSK | 1.42928516 |
| 27 | MAP3K7 | 1.42048961 |
| 28 | SMG1 | 1.41943750 |
| 29 | PRKD2 | 1.37465558 |
| 30 | TAOK1 | 1.37048714 |
| 31 | CDC42BPA | 1.36512454 |
| 32 | SIK3 | 1.33104607 |
| 33 | MAP3K6 | 1.29597985 |
| 34 | PKN2 | 1.27893714 |
| 35 | CDK12 | 1.23968519 |
| 36 | JAK3 | 1.16978554 |
| 37 | IKBKE | 1.16186157 |
| 38 | EEF2K | 1.12207082 |
| 39 | MAP3K3 | 1.11691301 |
| 40 | HCK | 1.09464855 |
| 41 | IRAK3 | 1.07081847 |
| 42 | MAP3K1 | 1.06894026 |
| 43 | PTK6 | 1.05945998 |
| 44 | SYK | 1.05036988 |
| 45 | TESK2 | 1.02238877 |
| 46 | MAP2K6 | 1.01765913 |
| 47 | BMX | 0.96794134 |
| 48 | TAOK2 | 0.95995049 |
| 49 | MAP2K2 | 0.94252796 |
| 50 | MAP3K10 | 0.94209270 |
| 51 | RPS6KA2 | 0.91507771 |
| 52 | KSR2 | 0.90050916 |
| 53 | RPS6KL1 | 0.89705945 |
| 54 | RPS6KC1 | 0.89705945 |
| 55 | FGR | 0.88662052 |
| 56 | MATK | 0.88058153 |
| 57 | CSF1R | 0.87654289 |
| 58 | JAK1 | 0.87344985 |
| 59 | KDR | 0.85600090 |
| 60 | MAPK15 | 0.84987120 |
| 61 | DYRK1B | 0.83547399 |
| 62 | MAPK12 | 0.82953190 |
| 63 | ITK | 0.82908222 |
| 64 | PDPK1 | 0.81895665 |
| 65 | LCK | 0.81241174 |
| 66 | IKBKB | 0.78559187 |
| 67 | LYN | 0.77867348 |
| 68 | TTN | 0.76617129 |
| 69 | HIPK2 | 0.75267062 |
| 70 | TXK | 0.74655648 |
| 71 | JAK2 | 0.74622697 |
| 72 | MAPK7 | 0.71609823 |
| 73 | RPS6KA6 | 0.71502183 |
| 74 | KIT | 0.70497695 |
| 75 | PDK1 | 0.69413268 |
| 76 | MST1R | 0.68030871 |
| 77 | CAMKK1 | 0.67922301 |
| 78 | RET | 0.67243794 |
| 79 | MARK3 | 0.61947822 |
| 80 | EPHA3 | 0.61777589 |
| 81 | FGFR3 | 0.56287391 |
| 82 | MAPK11 | 0.54308756 |
| 83 | MTOR | 0.51456949 |
| 84 | DDR2 | 0.49470644 |
| 85 | TAOK3 | 0.48090315 |
| 86 | FYN | 0.48001352 |
| 87 | PDGFRA | 0.46135837 |
| 88 | TYRO3 | 0.45952730 |
| 89 | CHUK | 0.45759227 |
| 90 | CDK4 | 0.45707163 |
| 91 | PRKD1 | 0.40828787 |
| 92 | MAPK4 | 0.39038467 |
| 93 | MAPKAPK2 | 0.37327923 |
| 94 | STK38 | 0.36643347 |
| 95 | MAPK3 | 0.35635485 |
| 96 | MAP2K4 | 0.34336289 |
| 97 | PDGFRB | 0.33564095 |
| 98 | ERBB2 | 0.33359942 |
| 99 | TESK1 | 0.32923735 |
| 100 | DAPK2 | 0.32733078 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Other glycan degradation_Homo sapiens_hsa00511 | 3.11378166 |
| 2 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.33393217 |
| 3 | Leishmaniasis_Homo sapiens_hsa05140 | 2.14257894 |
| 4 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.13593382 |
| 5 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.98086027 |
| 6 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.96746787 |
| 7 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.85480355 |
| 8 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.83084970 |
| 9 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.81266888 |
| 10 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.74360987 |
| 11 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.73948777 |
| 12 | Allograft rejection_Homo sapiens_hsa05330 | 1.66791221 |
| 13 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.65551351 |
| 14 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.63909784 |
| 15 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.60903164 |
| 16 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.60622709 |
| 17 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.51348635 |
| 18 | Tuberculosis_Homo sapiens_hsa05152 | 1.49868838 |
| 19 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.49683875 |
| 20 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.49487700 |
| 21 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.45164528 |
| 22 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.40474252 |
| 23 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.40328858 |
| 24 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.38787464 |
| 25 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.32556557 |
| 26 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.29794644 |
| 27 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.28647815 |
| 28 | Influenza A_Homo sapiens_hsa05164 | 1.28476623 |
| 29 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.27679938 |
| 30 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.24163220 |
| 31 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.22858060 |
| 32 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.21361026 |
| 33 | Malaria_Homo sapiens_hsa05144 | 1.20126860 |
| 34 | Measles_Homo sapiens_hsa05162 | 1.16504998 |
| 35 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.14139516 |
| 36 | Hepatitis C_Homo sapiens_hsa05160 | 1.13553582 |
| 37 | Lysosome_Homo sapiens_hsa04142 | 1.10802528 |
| 38 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.10580296 |
| 39 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 1.09639884 |
| 40 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.08116107 |
| 41 | Viral myocarditis_Homo sapiens_hsa05416 | 1.07590558 |
| 42 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.06875541 |
| 43 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.05662315 |
| 44 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.05190447 |
| 45 | Hepatitis B_Homo sapiens_hsa05161 | 1.03031090 |
| 46 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 1.00837514 |
| 47 | Pertussis_Homo sapiens_hsa05133 | 1.00697867 |
| 48 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.00085270 |
| 49 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.99625284 |
| 50 | Platelet activation_Homo sapiens_hsa04611 | 0.97863753 |
| 51 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.96541437 |
| 52 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.95757985 |
| 53 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.95500884 |
| 54 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.94732099 |
| 55 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.94522106 |
| 56 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.91801902 |
| 57 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.91751401 |
| 58 | Endocytosis_Homo sapiens_hsa04144 | 0.89901525 |
| 59 | Asthma_Homo sapiens_hsa05310 | 0.89422203 |
| 60 | Apoptosis_Homo sapiens_hsa04210 | 0.88986439 |
| 61 | Shigellosis_Homo sapiens_hsa05131 | 0.88510147 |
| 62 | Salmonella infection_Homo sapiens_hsa05132 | 0.88378510 |
| 63 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.85577760 |
| 64 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.82810408 |
| 65 | Phagosome_Homo sapiens_hsa04145 | 0.80291872 |
| 66 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.79307372 |
| 67 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.78391976 |
| 68 | Insulin resistance_Homo sapiens_hsa04931 | 0.76991930 |
| 69 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.75087091 |
| 70 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.73633792 |
| 71 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.71721228 |
| 72 | Endometrial cancer_Homo sapiens_hsa05213 | 0.71016826 |
| 73 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.70729163 |
| 74 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.70584200 |
| 75 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.69768374 |
| 76 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.69750498 |
| 77 | Prion diseases_Homo sapiens_hsa05020 | 0.69425151 |
| 78 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.69054227 |
| 79 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.68289344 |
| 80 | Bladder cancer_Homo sapiens_hsa05219 | 0.68055069 |
| 81 | Legionellosis_Homo sapiens_hsa05134 | 0.67054599 |
| 82 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.66322747 |
| 83 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.65009077 |
| 84 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.64570590 |
| 85 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.63993465 |
| 86 | Amoebiasis_Homo sapiens_hsa05146 | 0.62999116 |
| 87 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.62997953 |
| 88 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.62674060 |
| 89 | HTLV-I infection_Homo sapiens_hsa05166 | 0.62222052 |
| 90 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.59903150 |
| 91 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.57201362 |
| 92 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.55856417 |
| 93 | Glioma_Homo sapiens_hsa05214 | 0.53298451 |
| 94 | ABC transporters_Homo sapiens_hsa02010 | 0.52992666 |
| 95 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.52398915 |
| 96 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.51165722 |
| 97 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.46098249 |
| 98 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.45130600 |
| 99 | Colorectal cancer_Homo sapiens_hsa05210 | 0.44481657 |
| 100 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.44477246 |

